ENTRY       hsa05169                    Pathway
NAME        Epstein-Barr virus infection - Homo sapiens (human)
DESCRIPTION Epstein-Barr virus (EBV) is a gamma-herpes virus that widely infects human populations predominantly at an early age but remains mostly asymptomatic. EBV has been linked to a wide spectrum of human malignancies, including nasopharyngeal carcinoma and other hematologic cancers, like Hodgkin's lymphoma, Burkitt's lymphoma (BL), B-cell immunoblastic lymphoma in HIV patients, and posttransplant-associated lymphoproliferative diseases.  EBV has the unique ability to establish life-long latent infection in primary human B lymphocytes. During latent infection, EBV expresses a small subset of genes, including 6 nuclear antigens (EBNA-1, -2, -3A, -3B, -3C, and -LP), 3 latent membrane proteins (LMP-1, -2A, and -2B), 2 small noncoding RNAs (EBER-1 and 2). On the basis of these latent gene expression, three different latency patterns associated with the types of cancers are recognized.
CLASS       Human Diseases; Infectious disease: viral
PATHWAY_MAP hsa05169  Epstein-Barr virus infection
NETWORK     nt06165  Epstein-Barr virus (EBV)
            nt06516  TNF signaling
            nt06517  TLR signaling
            nt06518  JAK-STAT signaling
            nt06519  RLR signaling
            nt06524  Apoptosis
            nt06537  TCR/BCR signaling
  ELEMENT   N00223  EBV EBNA1 to p53-mediated transcription
            N00224  EBV EBNALP RBP-Jk-mediated transcription
            N00225  EBV EBNA2 to RBP-Jk-mediated transcription
            N00226  EBV EBNA3A/3B/3C to RBP-Jk-mediated transcription
            N00262  EBV EBNA3C to intrinsic apoptotic pathway
            N00263  EBV EBNA3C to p53-mediated transcription
            N00264  EBV EBNA3C to p27-Cell cycle G1/S
            N00265  EBV LMP1 to NFKB signaling pathway
            N00266  EBV LMP2A to PI3K signaling pathway
            N00466  EBV BPLF1 to TLR2/4-NFKB signaling pathway
            N00467  EBV BPLF1 to TLR2/4-NFKB signaling pathway
            N00468  EBV BPLF1 to TLR2/4-NFKB signaling pathway
            N00470  EBV BGLF4 to RIG-I-like receptor signaling pathway
            N00471  EBV LMP2A/2B to IFN signaling pathway
            N00472  EBV LMP1 to IFN signaling pathway
            N00473  EBV BGLF4 to IFN signaling pathway
            N00474  EBV BHRF1 to intrinsic apoptotic pathway
            N00475  EBV BHRF1 to intrinsic apoptotic pathway
            N00476  EBV BHRF1 to intrinsic apoptotic pathway
            N00477  EBV BHRF1 to crosstalk between extrinsic and intrinsic apoptotic pathways
            N00478  EBV BARF1 to intrinsic apoptotic pathway
            N00479  EBV BNLF2a to antigen processing and presentation by MHC class I molecules
            N00480  EBV BILF1 to antigen processing and presentation by MHC class I molecules
            N00481  EBV BZLF1 to p53-mediated transcription
            N00482  EBV EBNA3C to p27-Cell cycle G1/S
            N00483  EBV EBNA3C to cell cycle G1/S
            N00484  EBV EBNA3C to cell cycle G1/S
            N00485  EBV LMP1 to PI3K signaling pathway
            N00486  EBV LMP1 to Jak-STAT signaling pathway
            N00488  EBV LMP2A to BCR signaling pathway
DISEASE     H00367  Infectious mononucleosis; Epstein-Barr virus (EBV) infection
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]
            10018  BCL2L11; BCL2 like 11 [KO:K16341]
            1017  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]
            1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
            1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
            10213  PSMD14; proteasome 26S subunit, non-ATPase 14 [KO:K03030]
            1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]
            1027  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]
            102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]
            10379  IRF9; interferon regulatory factor 9 [KO:K04693]
            10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]
            10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]
            110117499  P3R3URF-PIK3R3; P3R3URF-PIK3R3 readthrough [KO:K02649]
            11047  ADRM1; ADRM1 26S proteasome ubiquitin receptor [KO:K06691]
            11317  RBPJL; recombination signal binding protein for immunoglobulin kappa J region like [KO:K06053]
            1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]
            1380  CR2; complement C3d receptor 2 [KO:K04012]
            1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]
            1643  DDB2; damage specific DNA binding protein 2 [KO:K10140]
            1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]
            1869  E2F1; E2F transcription factor 1 [KO:K17454]
            1870  E2F2; E2F transcription factor 2 [KO:K09389]
            1871  E2F3; E2F transcription factor 3 [KO:K06620]
            207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]
            208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]
            2208  FCER2; Fc epsilon receptor II [KO:K06468]
            22938  SNW1; SNW domain containing 1 [KO:K06063]
            23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]
            23586  RIGI; RNA sensor RIG-I [KO:K12646] [EC:5.6.2.6]
            25942  SIN3A; SIN3 transcription regulator family member A [KO:K11644]
            29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]
            2923  PDIA3; protein disulfide isomerase family A member 3 [KO:K08056] [EC:5.3.4.1]
            29760  BLNK; B cell linker [KO:K07371]
            3065  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]
            3066  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]
            3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]
            3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]
            3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]
            3108  HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]
            3109  HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]
            3111  HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]
            3112  HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]
            3113  HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]
            3115  HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]
            3117  HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]
            3118  HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]
            3119  HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]
            3120  HLA-DQB2; major histocompatibility complex, class II, DQ beta 2 [KO:K06752]
            3122  HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]
            3123  HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752]
            3125  HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752]
            3126  HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752]
            3127  HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752]
            3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]
            3134  HLA-F; major histocompatibility complex, class I, F [KO:K06751]
            3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]
            317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]
            3280  HES1; hes family bHLH transcription factor 1 [KO:K06054]
            3383  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
            3439  IFNA1; interferon alpha 1 [KO:K05414]
            3440  IFNA2; interferon alpha 2 [KO:K05414]
            3441  IFNA4; interferon alpha 4 [KO:K05414]
            3442  IFNA5; interferon alpha 5 [KO:K05414]
            3443  IFNA6; interferon alpha 6 [KO:K05414]
            3444  IFNA7; interferon alpha 7 [KO:K05414]
            3445  IFNA8; interferon alpha 8 [KO:K05414]
            3446  IFNA10; interferon alpha 10 [KO:K05414]
            3447  IFNA13; interferon alpha 13 [KO:K05414]
            3448  IFNA14; interferon alpha 14 [KO:K05414]
            3449  IFNA16; interferon alpha 16 [KO:K05414]
            3451  IFNA17; interferon alpha 17 [KO:K05414]
            3452  IFNA21; interferon alpha 21 [KO:K05414]
            3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]
            3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]
            3456  IFNB1; interferon beta 1 [KO:K05415]
            3516  RBPJ; recombination signal binding protein for immunoglobulin kappa J region [KO:K06053]
            355  FAS; Fas cell surface death receptor [KO:K04390]
            3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]
            3569  IL6; interleukin 6 [KO:K05405]
            3627  CXCL10; C-X-C motif chemokine ligand 10 [KO:K12671]
            3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]
            3661  IRF3; interferon regulatory factor 3 [KO:K05411]
            3665  IRF7; interferon regulatory factor 7 [KO:K09447]
            3683  ITGAL; integrin subunit alpha L [KO:K05718]
            3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]
            3718  JAK3; Janus kinase 3 [KO:K11218] [EC:2.7.10.2]
            3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]
            377841  ENTPD8; ectonucleoside triphosphate diphosphohydrolase 8 [KO:K01510] [EC:3.6.1.5]
            4067  LYN; LYN proto-oncogene, Src family tyrosine kinase [KO:K05854] [EC:2.7.10.2]
            4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]
            4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]
            4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]
            4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]
            4734  NEDD4; NEDD4 E3 ubiquitin protein ligase [KO:K10591] [EC:2.3.2.26]
            4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]
            4791  NFKB2; nuclear factor kappa B subunit 2 [KO:K04469]
            4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]
            4793  NFKBIB; NFKB inhibitor beta [KO:K02581]
            4794  NFKBIE; NFKB inhibitor epsilon [KO:K05872]
            4938  OAS1; 2'-5'-oligoadenylate synthetase 1 [KO:K14216] [EC:2.7.7.84]
            4939  OAS2; 2'-5'-oligoadenylate synthetase 2 [KO:K14216] [EC:2.7.7.84]
            4940  OAS3; 2'-5'-oligoadenylate synthetase 3 [KO:K14216] [EC:2.7.7.84]
            51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]
            51426  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]
            54205  CYCS; cytochrome c, somatic [KO:K08738]
            5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
            5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
            5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
            5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
            5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
            5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]
            5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]
            5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]
            5610  EIF2AK2; eukaryotic translation initiation factor 2 alpha kinase 2 [KO:K16195] [EC:2.7.11.1]
            567  B2M; beta-2-microglobulin [KO:K08055]
            5700  PSMC1; proteasome 26S subunit, ATPase 1 [KO:K03062]
            5701  PSMC2; proteasome 26S subunit, ATPase 2 [KO:K03061]
            5702  PSMC3; proteasome 26S subunit, ATPase 3 [KO:K03065]
            5704  PSMC4; proteasome 26S subunit, ATPase 4 [KO:K03063]
            5705  PSMC5; proteasome 26S subunit, ATPase 5 [KO:K03066]
            5706  PSMC6; proteasome 26S subunit, ATPase 6 [KO:K03064]
            5707  PSMD1; proteasome 26S subunit, non-ATPase 1 [KO:K03032]
            5708  PSMD2; proteasome 26S subunit ubiquitin receptor, non-ATPase 2 [KO:K03028]
            5709  PSMD3; proteasome 26S subunit, non-ATPase 3 [KO:K03033]
            5710  PSMD4; proteasome 26S subunit ubiquitin receptor, non-ATPase 4 [KO:K03029]
            5713  PSMD7; proteasome 26S subunit, non-ATPase 7 [KO:K03038]
            5714  PSMD8; proteasome 26S subunit, non-ATPase 8 [KO:K03031]
            5717  PSMD11; proteasome 26S subunit, non-ATPase 11 [KO:K03036]
            5718  PSMD12; proteasome 26S subunit, non-ATPase 12 [KO:K03035]
            5719  PSMD13; proteasome 26S subunit, non-ATPase 13 [KO:K03039]
            57506  MAVS; mitochondrial antiviral signaling protein [KO:K12648]
            578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]
            581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]
            5879  RAC1; Rac family small GTPase 1 [KO:K04392]
            5925  RB1; RB transcriptional corepressor 1 [KO:K06618]
            595  CCND1; cyclin D1 [KO:K04503]
            596  BCL2; BCL2 apoptosis regulator [KO:K02161]
            5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]
            5971  RELB; RELB proto-oncogene, NF-kB subunit [KO:K09253]
            6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
            637  BID; BH3 interacting domain death agonist [KO:K04726]
            6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]
            6502  SKP2; S-phase kinase associated protein 2 [KO:K03875]
            6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]
            6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]
            6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]
            6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]
            6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]
            6890  TAP1; transporter 1, ATP binding cassette subfamily B member [KO:K05653] [EC:7.4.2.14]
            6891  TAP2; transporter 2, ATP binding cassette subfamily B member [KO:K05654] [EC:7.4.2.14]
            6892  TAPBP; TAP binding protein [KO:K08058]
            695  BTK; Bruton tyrosine kinase [KO:K07370] [EC:2.7.10.2]
            7097  TLR2; toll like receptor 2 [KO:K10159]
            7124  TNF; tumor necrosis factor [KO:K03156]
            7128  TNFAIP3; TNF alpha induced protein 3 [KO:K11859] [EC:3.4.19.12]
            7157  TP53; tumor protein p53 [KO:K04451]
            7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]
            7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]
            7188  TRAF5; TNF receptor associated factor 5 [KO:K09849]
            7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]
            7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]
            7431  VIM; vimentin [KO:K07606]
            7874  USP7; ubiquitin specific peptidase 7 [KO:K11838] [EC:3.4.19.12]
            79685  SAP30L; SAP30 like [KO:K19202]
            7979  SEM1; SEM1 26S proteasome subunit [KO:K10881]
            811  CALR; calreticulin [KO:K08057]
            836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]
            841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]
            842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]
            8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]
            864  RUNX3; RUNX family transcription factor 3 [KO:K09279]
            8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]
            8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]
            8772  FADD; Fas associated via death domain [KO:K02373]
            8819  SAP30; Sin3A associated protein 30 [KO:K19202]
            890  CCNA2; cyclin A2 [KO:K06627]
            8900  CCNA1; cyclin A1 [KO:K06627]
            894  CCND2; cyclin D2 [KO:K10151]
            896  CCND3; cyclin D3 [KO:K10152]
            898  CCNE1; cyclin E1 [KO:K06626]
            9020  MAP3K14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]
            9134  CCNE2; cyclin E2 [KO:K06626]
            915  CD3D; CD3 delta subunit of T-cell receptor complex [KO:K06450]
            916  CD3E; CD3 epsilon subunit of T-cell receptor complex [KO:K06451]
            917  CD3G; CD3 gamma subunit of T-cell receptor complex [KO:K06452]
            919  CD247; CD247 molecule [KO:K06453]
            930  CD19; CD19 molecule [KO:K06465]
            953  ENTPD1; ectonucleoside triphosphate diphosphohydrolase 1 [KO:K01510] [EC:3.6.1.5]
            9541  CIR1; corepressor interacting with RBPJ, CIR1 [KO:K06066]
            956  ENTPD3; ectonucleoside triphosphate diphosphohydrolase 3 [KO:K01510] [EC:3.6.1.5]
            958  CD40; CD40 molecule [KO:K03160]
            960  CD44; CD44 molecule (IN blood group) [KO:K06256]
            9612  NCOR2; nuclear receptor corepressor 2 [KO:K06065]
            9636  ISG15; ISG15 ubiquitin like modifier [KO:K12159]
            9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]
            965  CD58; CD58 molecule [KO:K06492]
            9861  PSMD6; proteasome 26S subunit, non-ATPase 6 [KO:K03037]
COMPOUND    C00076  Calcium cation
            C01245  D-myo-Inositol 1,4,5-trisphosphate
            C05981  Phosphatidylinositol-3,4,5-trisphosphate
REFERENCE   PMID:15510157
  AUTHORS   Young LS, Rickinson AB.
  TITLE     Epstein-Barr virus: 40 years on.
  JOURNAL   Nat Rev Cancer 4:757-68 (2004)
            DOI:10.1038/nrc1452
REFERENCE   PMID:21372216
  AUTHORS   Saha A, Robertson ES
  TITLE     Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.
  JOURNAL   Clin Cancer Res 17:3056-63 (2011)
            DOI:10.1158/1078-0432.CCR-10-2578
REFERENCE   PMID:21429244
  AUTHORS   Ning S
  TITLE     Innate immune modulation in EBV infection.
  JOURNAL   Herpesviridae 2:1 (2011)
            DOI:10.1186/2042-4280-2-1
REFERENCE   PMID:28408983
  AUTHORS   Stanfield BA, Luftig MA
  TITLE     Recent advances in understanding Epstein-Barr virus.
  JOURNAL   F1000Res 6:386 (2017)
            DOI:10.12688/f1000research.10591.1
REFERENCE   PMID:24586164
  AUTHORS   van Gent M, Braem SG, de Jong A, Delagic N, Peeters JG, Boer IG, Moynagh PN, Kremmer E, Wiertz EJ, Ovaa H, Griffin BD, Ressing ME
  TITLE     Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling.
  JOURNAL   PLoS Pathog 10:e1003960 (2014)
            DOI:10.1371/journal.ppat.1003960
REFERENCE   PMID:23850008
  AUTHORS   Rajsbaum R, Garcia-Sastre A
  TITLE     Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways.
  JOURNAL   Trends Microbiol 21:421-9 (2013)
            DOI:10.1016/j.tim.2013.06.006
REFERENCE   PMID:25704559
  AUTHORS   Hoffmann HH, Schneider WM, Rice CM
  TITLE     Interferons and viruses: an evolutionary arms race of molecular interactions.
  JOURNAL   Trends Immunol 36:124-38 (2015)
            DOI:10.1016/j.it.2015.01.004
REFERENCE   PMID:22110506
  AUTHORS   Spender LC, Inman GJ
  TITLE     Inhibition of germinal centre apoptotic programmes by epstein-barr virus.
  JOURNAL   Adv Hematol 2011:829525 (2011)
            DOI:10.1155/2011/829525
REFERENCE   PMID:23303627
  AUTHORS   Fu Q, He C, Mao ZR
  TITLE     Epstein-Barr virus interactions with the Bcl-2 protein family and apoptosis in human tumor cells.
  JOURNAL   J Zhejiang Univ Sci B 14:8-24 (2013)
            DOI:10.1631/jzus.B1200189
REFERENCE   PMID:29116588
  AUTHORS   Wang Y, Banerjee S, Ding L, Cai C, Wei F, Cai Q
  TITLE     The regulatory role of protein phosphorylation in human gammaherpesvirus associated cancers.
  JOURNAL   Virol Sin 32:357-368 (2017)
            DOI:10.1007/s12250-017-4081-9
REFERENCE   PMID:23435233
  AUTHORS   Melchjorsen J
  TITLE     Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.
  JOURNAL   Viruses 5:470-527 (2013)
            DOI:10.3390/v5020470
REFERENCE   PMID:19498380
  AUTHORS   Hansen TH, Bouvier M
  TITLE     MHC class I antigen presentation: learning from viral evasion strategies.
  JOURNAL   Nat Rev Immunol 9:503-13 (2009)
            DOI:10.1038/nri2575
REFERENCE   PMID:18977445
  AUTHORS   Ressing ME, Horst D, Griffin BD, Tellam J, Zuo J, Khanna R, Rowe M, Wiertz EJ
  TITLE     Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
  JOURNAL   Semin Cancer Biol 18:397-408 (2008)
            DOI:10.1016/j.semcancer.2008.10.008
REFERENCE   PMID:21146386
  AUTHORS   Horst D, Verweij MC, Davison AJ, Ressing ME, Wiertz EJ
  TITLE     Viral evasion of T cell immunity: ancient mechanisms offering new applications.
  JOURNAL   Curr Opin Immunol 23:96-103 (2011)
            DOI:10.1016/j.coi.2010.11.005
REFERENCE   PMID:27886133
  AUTHORS   Ghosh Roy S, Robertson ES, Saha A
  TITLE     Epigenetic Impact on EBV Associated B-Cell Lymphomagenesis.
  JOURNAL   Biomolecules 6:E46 (2016)
            DOI:10.3390/biom6040046
REFERENCE   PMID:22249143
  AUTHORS   Dawson CW, Port RJ, Young LS
  TITLE     The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC).
  JOURNAL   Semin Cancer Biol 22:144-53 (2012)
            DOI:10.1016/j.semcancer.2012.01.004
REFERENCE   PMID:25613730
  AUTHORS   Cai Q, Chen K, Young KH
  TITLE     Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.
  JOURNAL   Exp Mol Med 47:e133 (2015)
            DOI:10.1038/emm.2014.105
REFERENCE   PMID:17601372
  AUTHORS   Zheng H, Li LL, Hu DS, Deng XY, Cao Y
  TITLE     Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.
  JOURNAL   Cell Mol Immunol 4:185-96 (2007)
REFERENCE   PMID:23793113
  AUTHORS   Ersing I, Bernhardt K, Gewurz BE
  TITLE     NF-kappaB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1.
  JOURNAL   Viruses 5:1587-606 (2013)
            DOI:10.3390/v5061587
REFERENCE   PMID:28835489
  AUTHORS   Wang LW, Jiang S, Gewurz BE
  TITLE     Epstein-Barr Virus LMP1-Mediated Oncogenicity.
  JOURNAL   J Virol 91:e01718-16 (2017)
            DOI:10.1128/JVI.01718-16
REFERENCE   PMID:12740915
  AUTHORS   Mori N, Morishita M, Tsukazaki T, Yamamoto N
  TITLE     Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
  JOURNAL   Int J Cancer 105:661-8 (2003)
            DOI:10.1002/ijc.11146
REFERENCE   PMID:25873381
  AUTHORS   Edwards RH, Marquitz AR, Raab-Traub N
  TITLE     Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.
  JOURNAL   MBio 6:e00441-15 (2015)
            DOI:10.1128/mBio.00441-15
REFERENCE   PMID:11905817
  AUTHORS   Thorley-Lawson DA
  TITLE     Epstein-Barr virus: exploiting the immune system.
  JOURNAL   Nat Rev Immunol 1:75-82 (2001)
            DOI:10.1038/35095584
REFERENCE   PMID:11669605
  AUTHORS   Eliopoulos AG, Young LS
  TITLE     LMP1 structure and signal transduction.
  JOURNAL   Semin Cancer Biol 11:435-44 (2001)
            DOI:10.1006/scbi.2001.0410
REFERENCE   PMID:14506283
  AUTHORS   Holowaty MN, Sheng Y, Nguyen T, Arrowsmith C, Frappier L
  TITLE     Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP.
  JOURNAL   J Biol Chem 278:47753-61 (2003)
            DOI:10.1074/jbc.M307200200
REFERENCE   PMID:25403939
  AUTHORS   Kang H, Kiess A, Chung CH
  TITLE     Emerging biomarkers in head and neck cancer in the era of genomics.
  JOURNAL   Nat Rev Clin Oncol 12:11-26 (2015)
            DOI:10.1038/nrclinonc.2014.192
REFERENCE   PMID:29932446
  AUTHORS   Tornesello ML, Annunziata C, Tornesello AL, Buonaguro L, Buonaguro FM
  TITLE     Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers.
  JOURNAL   Cancers (Basel) 10:E213 (2018)
            DOI:10.3390/cancers10070213
REFERENCE   PMID:19649319
  AUTHORS   Sato Y, Kamura T, Shirata N, Murata T, Kudoh A, Iwahori S, Nakayama S, Isomura H, Nishiyama Y, Tsurumi T
  TITLE     Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex.
  JOURNAL   PLoS Pathog 5:e1000530 (2009)
            DOI:10.1371/journal.ppat.1000530
REFERENCE   PMID:19244339
  AUTHORS   Saha A, Murakami M, Kumar P, Bajaj B, Sims K, Robertson ES
  TITLE     Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.
  JOURNAL   J Virol 83:4652-69 (2009)
            DOI:10.1128/JVI.02408-08
REFERENCE   PMID:19394062
  AUTHORS   Yi F, Saha A, Murakami M, Kumar P, Knight JS, Cai Q, Choudhuri T, Robertson ES
  TITLE     Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.
  JOURNAL   Virology 388:236-47 (2009)
            DOI:10.1016/j.virol.2009.03.027
REFERENCE   PMID:25635182
  AUTHORS   Kumar P, Murakami M, Kaul R, Saha A, Cai Q, Robertson ES
  TITLE     Deregulation of the cell cycle machinery by Epstein-Barr virus nuclear antigen 3C.
  JOURNAL   Future Virol 4:79-91 (2009)
            DOI:10.2217/17460794.4.1.79
REFERENCE   PMID:10818681
  AUTHORS   Longnecker R
  TITLE     Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
  JOURNAL   Adv Cancer Res 79:175-200 (2000)
            DOI:10.1016/s0065-230x(00)79006-3
REFERENCE   PMID:30116721
  AUTHORS   El-Sharkawy A, Al Zaidan L, Malki A
  TITLE     Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis.
  JOURNAL   Front Oncol 8:265 (2018)
            DOI:10.3389/fonc.2018.00265
REFERENCE   PMID:12811813
  AUTHORS   Dolcetti R, Masucci MG
  TITLE     Epstein-Barr virus: induction and control of cell transformation.
  JOURNAL   J Cell Physiol 196:207-18 (2003)
            DOI:10.1002/jcp.10263
REFERENCE   PMID:21347341
  AUTHORS   Saha A, Halder S, Upadhyay SK, Lu J, Kumar P, Murakami M, Cai Q, Robertson ES
  TITLE     Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.
  JOURNAL   PLoS Pathog 7:e1001275 (2011)
            DOI:10.1371/journal.ppat.1001275
REL_PATHWAY hsa03050  Proteasome
            hsa04010  MAPK signaling pathway
            hsa04020  Calcium signaling pathway
            hsa04064  NF-kappa B signaling pathway
            hsa04110  Cell cycle
            hsa04115  p53 signaling pathway
            hsa04210  Apoptosis
            hsa04612  Antigen processing and presentation
            hsa04620  Toll-like receptor signaling pathway
            hsa04622  RIG-I-like receptor signaling pathway
            hsa04630  JAK-STAT signaling pathway
            hsa04662  B cell receptor signaling pathway
KO_PATHWAY  ko05169
///
